Metraipolis › archive › dc_45e75daf048b

Characterization of Synthesized Ramucirumab-vcMMAE as a Potential Therapeutic Approach in Ovarian Cancer — Europe PMC PMID:40949250

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40949250
DOI
10.1021/acsomega.5c03733
License (as archived)
solo-consultazione
Archived
2026-11-10T07:43:02.899Z
SHA-256 of the archived text
b8dab8425c3f0519becaeb0bd5ce4e4cbffd13c3c48587b2eda8ca161f0a960d
Stable URL of this page
https://metraipolis.com/documento/dc_45e75daf048b

How to cite

Characterization of Synthesized Ramucirumab-vcMMAE as a Potential Therapeutic Approach in Ovarian Cancer — Europe PMC PMID:40949250 — Europe PMC (en), https://europepmc.org/article/MED/40949250 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_45e75daf048b (Metraipolis archive dc_45e75daf048b, sha256 b8dab8425c3f0519becaeb0bd5ce4e4cbffd13c3c48587b2eda8ca161f0a960d)
BibTeX
@misc{dc45e75daf048b,
  title = {Characterization of Synthesized Ramucirumab-vcMMAE as a Potential Therapeutic Approach in Ovarian Cancer — Europe PMC PMID:40949250},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40949250},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_45e75daf048b; sha256 b8dab8425c3f0519becaeb0bd5ce4e4cbffd13c3c48587b2eda8ca161f0a960d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40949250. Agents can read the archived copy with the MCP tool read_document.